Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Omar Ishrak
Omar Ishrak is Director at Amgen. OQRO lists 4 transactions filed with the SEC under this name, the latest on Aug 11, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
1
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.